- Home
- HOPE vs RCUS Comparison
HOPE vs RCUS Comparison
Compare HOPE & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOPE
- RCUS
- Stock Information
- Founded
- HOPE 1986
- RCUS 2015
- Country
- HOPE United States
- RCUS United States
- Employees
- HOPE N/A
- RCUS N/A
- Industry
- HOPE Major Banks
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- HOPE Finance
- RCUS Health Care
- Exchange
- HOPE Nasdaq
- RCUS Nasdaq
- Market Cap
- HOPE 1.4B
- RCUS 1.2B
- IPO Year
- HOPE 1996
- RCUS 2018
- Fundamental
- Price
- HOPE $10.47
- RCUS $16.36
- Analyst Decision
- HOPE Buy
- RCUS Buy
- Analyst Count
- HOPE 2
- RCUS 8
- Target Price
- HOPE $13.25
- RCUS $26.00
- AVG Volume (30 Days)
- HOPE 756.1K
- RCUS 1.1M
- Earning Date
- HOPE 10-28-2025
- RCUS 11-05-2025
- Dividend Yield
- HOPE 5.12%
- RCUS N/A
- EPS Growth
- HOPE N/A
- RCUS N/A
- EPS
- HOPE 0.34
- RCUS N/A
- Revenue
- HOPE $412,692,000.00
- RCUS $262,000,000.00
- Revenue This Year
- HOPE $17.88
- RCUS N/A
- Revenue Next Year
- HOPE $11.76
- RCUS N/A
- P/E Ratio
- HOPE $32.12
- RCUS N/A
- Revenue Growth
- HOPE N/A
- RCUS 6.07
- 52 Week Low
- HOPE $8.83
- RCUS $6.50
- 52 Week High
- HOPE $14.54
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- HOPE 42.22
- RCUS 67.34
- Support Level
- HOPE $10.52
- RCUS $15.38
- Resistance Level
- HOPE $11.13
- RCUS $17.19
- Average True Range (ATR)
- HOPE 0.27
- RCUS 1.07
- MACD
- HOPE -0.03
- RCUS 0.20
- Stochastic Oscillator
- HOPE 10.40
- RCUS 73.27
About HOPE Hope Bancorp Inc.
Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services and other banking services.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.